While some Australians celebrate access to new medicines, others are forced to fundraise for treatments they desperately need ...

FDA approves Neffy 1 mg for children aged 4+ weighing 15 to <30 kg for allergic reactions. Most insured patients can access Neffy for $25, while cash price is $199 for two doses. Get our list of 10 ...

Earlier this month, the FDA approved ARS Pharmaceuticals Inc’s (NASDAQ:SPRY) neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I), including those that are ...

Add Yahoo as a preferred source to see more of our stories on Google. Aug. 26—Those at risk of a severe allergic reaction always have handy an EpiPen just in case. But soon their life might be saved ...

Many patients will continue to face higher out-of-pocket costs or rely on the company’s cash-pay option without broader ...

Neffy is a needle-free nasal spray approved by the FDA for severe allergic reactions, including anaphylaxis. The recommended dosage of Neffy depends on someone’s body weight in kilograms. It is ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA approved Neffy, the first nasal epinephrine drug for treating severe allergies, pictured here in a screenshot from a ...

ARS Pharmaceuticals, Inc. shares fell in after-hours trading on Wednesday after the company provided commercial and financial ...

The FDA’s Office of Prescription Drug Promotion (OPDP) has issued a pointed warning to ARS Pharmaceutical Operations, calling its direct-to-consumer television advertisement for Neffy (epinephrine ...

Allergic reactions, especially when severe, can be pretty scary. In the case of anaphylaxis, a life-threatening allergic reaction, the treatment typically involves the administration of epinephrine, a ...

Shares of ARS Pharmaceuticals fell after the company said no commercial insurers had added its neffy nasal spray to their plans in the current insurance cycle. Shares plunged 23% to $8.12 in ...